Results 91 to 100 of about 272,431 (201)

Experiences and Lessons Learned from the Measles-Rubella Vaccination Campaign 2023 Implemented in Private Schools of Kolkata

Indian Journal of Community Medicine
Background: Measles-Rubella vaccination campaign (MRVC) was conducted in West Bengal with a target to achieve more than 95% vaccination among children aged 9 months to 15 years.
Poulomi Mukherjee, Mousumi Datta, Arup Chakraborty, Debasis Das   +3 more
doaj   +1 more source

COVID-19 mass vaccination - an illustration of the impact of syringe choice on the effectiveness of mass vaccination campaigns. [PDF]

Emerg Microbes Infect, 2022
Roseline M, Luc C, Julien L, Olivier E, Etienne B, Pierrick B.   +5 more
europepmc   +1 more source

Novel particulate vaccine candidates recombinantly produced by pathogenic and nonpathogenic bacterial hosts : a thesis presented in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Microbiology at Massey University, Manawatu, New Zealand. [PDF]

, 2017
Polyhydroxyalkanoates (PHAs) are biopolyesters synthesized as small spherical cytoplasmic inclusion bodies by a range of bacteria. Recently, PHA beads have been investigated for use as a vaccine delivery platform by using engineered heterologous ...
Lee, Jason Wong
core  

COVID-19 vaccination hesitancy and challenges to mass vaccination [PDF]

Hong Kong Medical Journal, 2021
openaire   +2 more sources

Public health impact of herpes zoster vaccination on older adults in Singapore: a modeling study

Human Vaccines & Immunotherapeutics
In Singapore, population aging and rising life expectancy are increasing herpes zoster (HZ) burden, which may be reduced by vaccination. The present study modeled the public health impact of HZ vaccination in Singapore using ZOster ecoNomic Analysis ...
Helen Oh, Carol Tan, Charles Williams, Nikolaos Giannelos, Cheryl Ng   +4 more
doaj   +1 more source

Seasonal mass vaccination with R21/Matrix-M for malaria elimination (SERVAL): protocol of the cluster randomised trial. [PDF]

Trials
Dabira ED, Natama HM, Jaiteh F, Grietens KP, Bocoum FY, Ndiath MO, Mohammed N, Gibba B, Hill AVS, Ghani A, Erhart A, Tinto H, D'Alessandro U.   +12 more
europepmc   +2 more sources

Setting up and managing the largest COVID-19 mass vaccination center in Lombardy, Italy. [PDF]

Front Public Health, 2023
Calegari JG, Bisesti A, Pazzaglia S, Gambazza S, Binda F, Bruno M, Chiappa L, Piatti A, Tiwana N, Letzgus M, Castaldi S, Sottocorno M, Laquintana D.   +12 more
europepmc   +1 more source

COVID-19 vaccination in the mass vaccination center: clinical practice and effectiveness analysis. [PDF]

Front Public Health, 2023
Fan J, Zhu L, Wu X, Luo C, Huang A, Wang W.   +5 more
europepmc   +1 more source

Genomic epidemiology of Vibrio cholerae during a mass vaccination campaign of displaced communities in Bangladesh. [PDF]

Nat Commun, 2023
Taylor-Brown A, Afrad MH, Khan AI, Lassalle F, Islam MT, Tanvir NA, Thomson NR, Qadri F.   +7 more
europepmc   +1 more source

Dengue Incidence Following Mass Vaccination: An Interrupted Time Series Study in Paraná, Brazil. [PDF]

Trop Med Infect Dis
Costa-Ribeiro MCVD, Krainski ET, Mello AM, Carvalho DS, Luhm KR, Diaz-Quijano FA, Raboni SM, Silva LRD, Buffon MDCM, Maluf EMCP, Graef G, Almeida GA, Preto C, Shimakura SE.   +13 more
europepmc   +1 more source